General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region ForumsDr. Fauci confirms Remdesivir is successful in treating COVID-19
Last edited Wed Apr 29, 2020, 01:11 PM - Edit history (1)
It's not a cure, but it does seem to help.
https://sanfrancisco.cbslocal.com/2020/04/29/coronavirus-dr-fauci-gilead-covid-19-nih-test-results/
More details here:
Fauci says Gilead reports the anti-viral reduced duration of COVID-19 from 15 to 11 days. "A drug can block this virus," said Fauci about the results of the drug trial. He says the mortality rate also fell from 11% to 8%. He calls the improvement "very important."
Link to tweet
Update. Clip from Dr. Fauci:
Link to tweet
Newest Reality
(12,712 posts)The side effects may be an issue, as well.
Globally, it is going to be an inexpensive drug.
Well, we'll see.
DrToast
(6,414 posts)Newest Reality
(12,712 posts)Separately on Wednesday, Gilead announced partial results from its own ongoing study of the drug in severely ill, hospitalized COVID-19 patients. The company said patients treated for five days achieved similar improvement in health as others treated for 10 days. However, that result is hard to interpret because there is no comparison group of people getting usual care, so its impossible to know how much patients would have improved on their own.
Doesn't that mean there was none?
DrToast
(6,414 posts)There are two separate studies making the news today.
One comparing 5-day vs. 10-day treatment course.
The other study is a randomized controlled trial being conducted by the NIH:
The study, run by the National Institutes of Health, tested remdesivir versus usual care in about 800 hospitalized coronavirus patients around the world. The main result is how long it takes patients to recover.
uponit7771
(93,532 posts)... we're waiting on the full NIH study.
DrToast
(6,414 posts)He's not talking about the Gilead study.
uponit7771
(93,532 posts)... drugs seeing they've done this before with Ebola and Rem.
We should wait on the full NIH report,
Newest Reality
(12,712 posts)I have read their history and it is very shady. It's available online.
I wonder if the Wall St. traders bother to do that, considering the perk they got from that sketchy news?
uponit7771
(93,532 posts)DrToast
(6,414 posts)You can read about the study design here:
A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center (UNMC) in Omaha.
https://www.nih.gov/news-events/news-releases/nih-clinical-trial-remdesivir-treat-covid-19-begins
jpak
(41,780 posts)So there was a true control group
uponit7771
(93,532 posts)... he is truly reporting just what a pumper like Gilead is reporting thing I'm disappointed
DrToast
(6,414 posts)uponit7771
(93,532 posts)... results have not been released and the NIH has not responded to inquiries.
Pumpers like Gilead play with words multiple times when it comes to drugs
Gilead who stock was up $4.48 to $83.15 in midday trading gave no details on results Wednesday, but said an announcement is expected soon. NIH officials did not immediately reply to a request for comment.
DrToast
(6,414 posts)It's right there in the article:
But Dr. Anthony Fauci called the NIH test results quite good news in a morning call with reporters.
DrToast
(6,414 posts)White House health advisor Dr. Anthony Fauci said Wednesday that data from a coronavirus drug trial testing Gilead Sciences antiviral drug remdesivir showed quite good news.
Speaking to reporters from the White House, Fauci said he was told data from the trial showed a clear cut positive effect in diminishing time to recover.
https://www.cnbc.com/2020/04/29/dr-anthony-fauci-says-data-from-remdesivir-coronavirus-drug-trial-shows-quite-good-news.html
uponit7771
(93,532 posts)... like the other have this morning.
DrToast
(6,414 posts)He's the director of the National Institute of Allergy and Infectious Diseases.
He's giving a preview of the results of the study.
He's not talking about the separate Gilead report.
Otherwise I'll eat being wrong with gladness knowing the caveats are this does ... NOT ... stop people from getting the virus
Oh dear god. That's not what the drug is for. It's a TREATMENT.
uponit7771
(93,532 posts)DrToast
(6,414 posts)But you know, the director of the National Institute of Allergy and Infectious Diseases just might be credible in talking about the results.
But hey, what does he know. I'm sure you know better.
uponit7771
(93,532 posts)... rate by some unknown factor.
DrToast
(6,414 posts)By preventing viral replication.
OMG....I'm done with you. Everything you've claimed in this thread has been disproven (there was a control group and Fauci is talking about the NIH results) and now you're just pretending you never said those things. We all can read your posts, you know.
uponit7771
(93,532 posts)DrToast
(6,414 posts)uponit7771
(93,532 posts)DrToast
(6,414 posts)uponit7771
(93,532 posts)... word games
Again, this is DU and we're not LIVs
LisaL
(47,423 posts)It's a drug. Not a vaccine.
Jeez.
uponit7771
(93,532 posts)... question if there was "nobody"
LisaL
(47,423 posts)uponit7771
(93,532 posts)uponit7771
(93,532 posts)... cares if my death date change.
I KNEW ... this was some bullshit.
Oh....so now you admit there WAS a control group.
And you acknowledge that Fauci was NOT talking about the separate Gilead study.
So now you're trying to move the goalposts and say it's bullshit because it's not a cure, but NOBODY ever said it was a cure.
Keep digging, man.
uponit7771
(93,532 posts)DenverJared
(457 posts)Gilead spokesperson Amy Flood said the company believes the post included inappropriate characterization of the study. Because the study was stopped early because it had too few patients, she said, it cannot enable statistically meaningful conclusions. However, she said, trends in the data suggest a potential benefit for remdesivir, particularly among patients treated early in disease.
https://www.statnews.com/2020/04/23/data-on-gileads-remdesivir-released-by-accident-show-no-benefit-for-coronavirus-patients/
But a Chinese trial showed that the drug had not been successful, according to draft documents accidentally published by the World Health Organization.
The drug did not improve patients' condition or reduce the pathogen's presence in the bloodstream, it said.
https://www.bbc.com/news/world-52406261
Fauci is full of shit.
uponit7771
(93,532 posts)... statement off of what the Gilead said which is still foolish cause he hasn't read the NIH report which hasn't released yet.
mr_lebowski
(33,643 posts)He's not just some schmo who'd necessarily have to wait for public release of something like this.
DrToast
(6,414 posts)The director of the National Institute of Allergy and Infectious Diseases just MIGHT know what the study says.
mr_lebowski
(33,643 posts)DrToast
(6,414 posts)uponit7771
(93,532 posts)... does show efficacy in time on sickness but the mortality drop was insignificant.
Fauci said this is a step in the right direction and not a vaccine.
LisaL
(47,423 posts)Drug is something that treats existing disease, vaccine is something that prevents someone from become sick.
They're attacking it because it doesn't do things nobody expected it would do.
It also doesn't do my laundry! It sucks!
LisaL
(47,423 posts)The drug is likely most effective when given early in the disease. It might be too late for severely ill patients.
DenverJared
(457 posts)doesn't automatically mean it works in another set of patients.
That is like saying a drug works in left handed people because it didn't work in right handed people.
LisaL
(47,423 posts)Isn't that what we are discussing here?
DenverJared
(457 posts)Reduction of 15 to 11 can happen by chance. There is no control group to provide statistical significance.
Giving strawberry yogurt could also provide similar results. Doesn't mean it works.
PCIntern
(28,366 posts)Its chloroquiniehydroxylatizine. Try haa as ts best. Forget this... Some people like to call it that. This other stuff...I dont know anything about it and dont own any stock in the company. And covfefe
Newest Reality
(12,712 posts)Capitalists at there best. I don't think I would buy a used car from them, but maybe I'm picky. Any better companies out there working on this?
Several class-action lawsuits have been filed against Gilead over allegations that the company deliberately delayed development of antiretroviral drugs based on tenofovir alafenamide fumarate (TAF) in order to maximize profits from previous-generation medications containing tenofovir disoproxil fumarate (TDF).[63] Plaintiffs allege that Gilead suspended TAF in 2004 despite clear evidence indicating that TAF-based medications were safer than TDF, a compound whose long-term use was associated with adverse side effects such as nephrotoxicity and bone density loss.[64][65] Gilead intentionally withheld results of clinical trials demonstrating TAF's relative safety and efficacy and shelved TAF-based therapies until 2010, when the Food and Drug Administration approved Gilead's application to patent TAF.[66] Gilead's first TAF medication, marketed under the trade name Genvoya, came out in 2015. In the interim period, many HIV patients who continuously took Gilead's older TDF-based drugs suffered permanent, debilitating kidney and bone damage, often developing conditions such as Fanconi syndrome and osteomalacia.[67]
Gilead has come under intense criticism for its high pricing of its patented drug sofosbuvir. In the US, for instance, it was launched at $1,000 per pill or $84,000 for the standard 84-day course.[68][69]
Gilead has also tried to eliminate competition in lucrative markets by entering voluntary licensing agreements (VLA) with companies from developing countries such as India, which mandated the limitation of the latter's operations to less lucrative markets. The company has also been criticized for creating harsh restrictions within countries where they have been denied rights, or are engaged in VLAs. For example, in India, they tried to create an 'anti-diversion' program to determine who could buy the drug, which was considered a coercive and policing move by Médecins Sans Frontières since it could lead to the exclusion of vulnerable groups like refugees and migrants from accessing the medicines.[70]
On January 21 2020, the Wuhan Institute of Virology applied for a Chinese "use patent" on remdesivir, for the novel use of treating COVID-19.[71]
Gilead sought and obtained "orphan drug" status for remdesivir from the US Food and Drug Administration on March 23rd, 2020. This provision is intended to encourage the development of drugs affecting fewer than 200,000 Americans by granting strengthened and extended legal monopoly rights to the manufacturer, along with waivers on taxes and government fees.[72][73] Remdesivir is a candidate for treating COVID-19; at the time the status was granted, fewer than 200,000 Americans had COVID-19, but numbers were climbing rapidly as the COVID-19 pandemic reached the US, and crossing the threshold soon was considered inevitable.[72][73] Remdesivir was developed by Gilead with over $79 million in U.S. government funding.[73] After facing strong reactions, Gilead gave up the "orphan drug" status for remdesivir on March 25th.[74] Gilead retains 20-year remdesivir patents in more than 70 countries.[75]
Gilead has also been accused of price-gouging on other medications developed with public funding, including AIDS PrEP drug Tenofovir and hepatitis C drug Sofosbuvir.[76]
https://en.wikipedia.org/wiki/Gilead_Sciences
roamer65
(37,953 posts)Not all, but some is better than none.
uponit7771
(93,532 posts)Goodheart
(5,760 posts)No control group + Small sample size + Manufacturer with profit motive = I ain't buying it.
DrToast
(6,414 posts)uponit7771
(93,532 posts)... direction and the lower mortality rate was insignificant.
LisaL
(47,423 posts)uponit7771
(93,532 posts)uponit7771
(93,532 posts)... but shows there's a drug that workds
GeorgeGist
(25,570 posts)but geniuses Fauci and Brix seem unaware of this finding.